RCUS - Arcus Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCUS is currently covered by 9 analysts with an average price target of $37.49. This is a potential upside of $22.79 (155.03%) from yesterday's end of day stock price of $14.7.

Arcus Biosciences's activity chart (see below) currently has 66 price targets and 79 ratings on display. The stock rating distribution of RCUS is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.55% with an average time for these price targets to be met of 209.92 days.

Highest price target for RCUS is $50, Lowest price target is $29, average price target is $37.49.

Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 25-Oct-2024. First documented stock forecast 09-Apr-2018.

Currently out of the existing stock ratings of RCUS, 32 are a BUY (94.12%), 2 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$29

$14.3 (97.28%)

$25

29 days ago
(25-Oct-2024)

3/7 (42.86%)

$12.68 (77.70%)

108

Buy

1 months 16 days ago
(07-Oct-2024)

0/2 (0%)

$19.99 (124.86%)

Buy

$30

$15.3 (104.08%)

$30

1 months 20 days ago
(03-Oct-2024)

3/12 (25%)

$14.69 (95.95%)

458

Buy

$46

4 months 18 days ago
(05-Jul-2024)

1/5 (20%)

$24.75 (116.47%)

13

Buy

$38

$23.3 (158.50%)

$44

5 months 20 days ago
(03-Jun-2024)

2/11 (18.18%)

$22.16 (139.90%)

294

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCUS (Arcus Biosciences) average time for price targets to be met?

On average it took 209.92 days on average for the stock forecasts to be realized with a an average price target met ratio 27.55

Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?

Robert Driscoll works at WEDBUSH and has 14 price targets and 9 ratings on RCUS

Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?

Kaveri Pohlman with highest potential upside - $50.9

Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?

Geoffrey Porges with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?